Terminated PHASE4 INTERVENTIONAL 2-arm NCT01066533

Immunohistochemical Study of Human Teeth Pulp Capped With Mineral Trioxide Aggregate (MTA) and Novel Endodontic Cement (NEC)

Histologic and Immunohistochemical Study of Fibronectin and Tenascin in Human Teeth Pulp Capped With MTA and NEC

Sponsor: Mashhad University of Medical Sciences

Interventions direct pulp capping and covering the exposed pulp

Updated 5 times since 2017 Last updated: Feb 9, 2010 Started: Oct 31, 2009 Primary completion: Dec 31, 2009 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

immunohistochemistry markers are not recieved yet

Other terminated trials from Mashhad University of Medical Sciences

See all terminations from Mashhad University of Medical Sciences

This PHASE4 trial investigates Direct Pulp Capping and is currently terminated or withdrawn. Mashhad University of Medical Sciences leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE4
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2017 — Jan 2021 [monthly]

Terminated PHASE4

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mashhad University of Medical Sciences
Shahid Beheshti University of Medical Sciences

Data source: Mashhad University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mashhad, Iran